Oxidative stress and inflammation are associated with adiposity in moderate to severe CKD

Journal of the American Society of Nephrology

Volumn 19, Issue 3, 2008, Pages 593-599

  Ramos, Luis F ^a   Shintani, Ayumi ^a   Ikizler, T Alp ^a   Himmelfarb, Jonathan ^b  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b MAINE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN; CHOLESTEROL; ISOPROSTANE DERIVATIVE; THIOL;

ADULT; ALBUMIN BLOOD LEVEL; ANTIOXIDANT ACTIVITY; ARTICLE; BODY FAT; BODY MASS; CHOLESTEROL BLOOD LEVEL; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; OBESITY; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RACE DIFFERENCE; SEX DIFFERENCE; SMOKING;

EID: 40449129185     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2007030355     Document Type: Article

References (32)

1. Jones CA, McQuillan GM, Kusek JW, Eberhardt MS, Herman WH, Coresh J, Salive M, Jones CP, Agodoa LY: Serum creatinine levels in the US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis 32: 992-999, 1998
2. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY: Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351: 1296-1305, 2004
3. Cheung AK, Sarnak MJ, Yan G, Dwyer JT, Heyka RJ, Rocco MV, Teehan BP, Levey AS: Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients. Kidney Int 58: 353-362, 2000
4. Yeun JY, Levine RA, Mantadilok V, Kaysen GA: C-Reactive protein predicts all-cause and cardiovascular mortality in hemodialysis patients. Am J Kidney Dis 35: 469-476, 2000
5. Locatelli F, Canaud B, Eckardt KU, Stenvinkel P, Wanner C, Zoccali C: Oxidative stress in end-stage renal disease: An emerging threat to patient outcome. Nephrol Dial Transplant 18: 1272-1280, 2003
6. Oberg BP, McMenamin E, Lucas FL, McMonagle E, Morrow J, Ikizler TA, Himmelfarb J: Increased prevalence of oxidant stress and inflammation in patients with moderate to severe chronic kidney disease. Kidney Int 65: 1009-1016, 2004
7. Himmelfarb J, McMonagle E, McMenamin E: Plasma protein thiol oxidation and carbonyl formation in chronic renal failure. Kidney Int 58: 2571-2578, 2000
8. Pecoits-Filho R, Heimburger O, Barany P, Suliman M, Fehrman-Ekholm I, Lindholm B, Stenvinkel P: Associations between circulating inflammatory markers and residual renal function in CRF patients. Am J Kidney Dis 41: 1212-1218, 2003
9. Gelber RP, Kurth T, Kausz AT, Manson JE, Buring JE, Levey AS, Gaziano JM: Association between body mass index and CKD in apparently healthy men. Am J Kidney Dis 46: 871-880, 2005
10. Ejerblad E, Fored CM, Lindblad P, Fryzek J, McLaughlin JK, Nyren O: Obesity and risk for chronic renal failure. J Am Soc Nephrol 17: 1695-1702, 2006
11. Hsu CY, McCulloch CE, Iribarren C, Darbinian J, Go AS: Body mass index and risk for end-stage renal disease. Ann Intern Med 144: 21-28, 2006
12. Berg AH, Scherer PE: Adipose tissue, inflammation, and cardiovascular disease. Circ Res 96: 939-949, 2005
13. Keaney JF Jr, Larson MG, Vasan RS, Wilson PW, Lipinska I, Corey D, Massaro JM, Sutherland P, Vita JA, Benjamin EJ: Obesity and systemic oxidative stress: Clinical correlates of oxidative stress in the Framingham Study. Arterioscler Thromb Vasc Biol 23: 434-439, 2003
14. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D: A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130: 461-470, 1999
15. Iseki K, Ikemiya Y, Kinjo K, Inoue T, Iseki C, Takishita S: Body mass index and the risk of development of end-stage renal disease in a screened cohort. Kidney Int 65: 1870-1876, 2004
16. Kramer H, Luke A, Bidani A, Cao G, Cooper R, McGee D: Obesity and prevalent and incident CKD: The Hypertension Detection and Follow-Up Program. Am J Kidney Dis 46: 587-594, 2005
17. Ramkumar N, Cheung AK, Pappas LM, Roberts WL, Beddhu S: Association of obesity with inflammation in chronic kidney disease: A cross-sectional study. J Ren Nutr 14: 201-207, 2004
18. Pecoits-Filho R, Nordfors L, Heimburger O, Lindholm B, Anderstam B, Marchlewska A, Stenvinkel P: Soluble leptin receptors and serum leptin in end-stage renal disease: Relationship with inflammation and body composition. Eur J Clin Invest 32: 811-817, 2002
19. Menon V, Wang X, Greene T, Beck GJ, Kusek JW, Marcovina SM, Levey AS, Sarnak MJ: Relationship between C-reactive protein, albumin, and cardiovascular disease in patients with chronic kidney disease. Am J Kidney Dis 42: 44-52, 2003
20. King AJ, Kehayias JJ, Roubenoff R, Schmid CH, Pereira BJ: Cytokine production and nutritional status in hemodialysis patients, Int J Artif Organs 21: 4-11, 1998
21. Friedman AN, Hunsicker LG, Selhub J, Bostom AG: Clinical and nutritional correlates of C-reactive protein in type 2 diabetic nephropathy. Atherosclerosis 172: 121-125, 2004
22. Roberts MA, Hare DL, Ratnaike S, Ierino FL: Cardiovascular biomarkers in CKD: Pathophysiology and implications for clinical management of cardiac disease. Am J Kidney Dis 48: 341-360, 2006
23. Park HS, Park JY, Yu R: Relationship of obesity and visceral adiposity with serum concentrations of CRP, TNF-alpha and IL-6. Diabetes Res Clin Pract 69: 29-35, 2005
24. Festa A, D'Agostino R Jr, Williams K, Karter AJ, Mayer-Davis EJ, Tracy RP, Haffner SM: The relation of body fat mass and distribution to markers of chronic inflammation. Int J Obes Relat Metab Disord 25: 1407-1415, 2001
25. Khan NI, Naz L, Yasmeen G: Obesity: An independent risk factor for systemic oxidative stress. Pak J Pharm Sci 19: 62-65, 2006
26. Vincent HK, Taylor AG: Biomarkers and potential mechanisms of obesity-induced oxidant stress in humans. Int J Obes (Lond) 30: 400-418, 2006
27. Wellen KE, Hotamisligil GS: Obesity-induced inflammatory changes in adipose tissue. J Clin Invest 112: 1785-1788, 2003
28. Foley RN, Murray AM, Li S, Herzog CA, McBean AM, Eggers PW, Collins AJ: Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States Medicare population, 1998 to 1999. J Am Soc Nephrol 16: 489-495, 2005
29. Morrow JD: The isoprostanes: Their quantification as an index of oxidant stress status in vivo. Drug Metab Rev 32: 377-385, 2000
30. Ellman GL: Tissue sulfhydryl groups. Arch Biochem Biophys 82: 70-77, 1959
31. Hu ML, Louie S, Cross CE, Motchnik P, Halliwell B: Antioxidant protection against hypochlorous acid in human plasma. J Lab Clin Med 121: 257-262, 1993
32. Lukaski HC, Johnson PE, Bolonchuk WW, Lykken GI: Assessment of fat-free mass using bioelectrical impedance measurements of the human body. Am J Clin Nutr 41: 810-817, 1985